Meeting Commentary: A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome (ARS)
Radiat Res
.
2021 Oct 1;196(4):423-428.
doi: 10.1667/RADE-21-00053.1.
Authors
Merriline M Satyamitra
1
,
David R Cassatt
1
,
Lanyn P Taliaferro
1
Affiliation
1
Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
PMID:
34270773
PMCID:
PMC8522554
DOI:
10.1667/RADE-21-00053.1
No abstract available
MeSH terms
Acute Radiation Syndrome*
Radiation-Protective Agents
Substances
Radiation-Protective Agents
Grants and funding
Z99 AI999999/ImNIH/Intramural NIH HHS/United States